Forte Biosciences, Inc. (FBRX)

Warunki handlu

Sesja handlowa (UTC)
poniedziałek: 11:00 - 00:00
wtorek - piątek: 00:00 - 00:30, 11:00 - 00:00
sobota: 00:00 - 00:30

O firmie

Forte Biosciences, Inc., formerly Tocagen Inc., is a clinical-stage biopharmaceutical company. The Company is focused on clinical program and developing a live biotherapeutic for the treatment of inflammatory skin diseases, particularly for pediatric atopic dermatitis patients. It provides FB-401, which is a live biotherapeutic for the treatment of inflammatory skin diseases. FB-401 has completed Phase I/II a testing in adult and pediatric patients with atopic dermatitis.

https://tocagen.com